CD38 Monoclonal Antibodies Market, Global Outlook and Forecast 2023-2028

Report ID: 1133817 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 CD38 Monoclonal Antibodies Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CD38 Monoclonal Antibodies Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CD38 Monoclonal Antibodies Overall Market Size
    2.1 Global CD38 Monoclonal Antibodies Market Size: 2021 VS 2028
    2.2 Global CD38 Monoclonal Antibodies Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CD38 Monoclonal Antibodies Players in Global Market
    3.2 Top Global CD38 Monoclonal Antibodies Companies Ranked by Revenue
    3.3 Global CD38 Monoclonal Antibodies Revenue by Companies
    3.4 Top 3 and Top 5 CD38 Monoclonal Antibodies Companies in Global Market, by Revenue in 2021
    3.5 Global Companies CD38 Monoclonal Antibodies Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CD38 Monoclonal Antibodies Players in Global Market
        3.6.1 List of Global Tier 1 CD38 Monoclonal Antibodies Companies
        3.6.2 List of Global Tier 2 and Tier 3 CD38 Monoclonal Antibodies Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global CD38 Monoclonal Antibodies Market Size Markets, 2021 & 2028
        4.1.2 Daratumumab
        4.1.3 Isatuximab
    4.2 By Type - Global CD38 Monoclonal Antibodies Revenue & Forecasts
        4.2.1 By Type - Global CD38 Monoclonal Antibodies Revenue, 2017-2022
        4.2.2 By Type - Global CD38 Monoclonal Antibodies Revenue, 2023-2028
        4.2.3 By Type - Global CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CD38 Monoclonal Antibodies Market Size, 2021 & 2028
        5.1.2 Pharmacy
        5.1.3 Laboratory Use
    5.2 By Application - Global CD38 Monoclonal Antibodies Revenue & Forecasts
        5.2.1 By Application - Global CD38 Monoclonal Antibodies Revenue, 2017-2022
        5.2.2 By Application - Global CD38 Monoclonal Antibodies Revenue, 2023-2028
        5.2.3 By Application - Global CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global CD38 Monoclonal Antibodies Market Size, 2021 & 2028
    6.2 By Region - Global CD38 Monoclonal Antibodies Revenue & Forecasts
        6.2.1 By Region - Global CD38 Monoclonal Antibodies Revenue, 2017-2022
        6.2.2 By Region - Global CD38 Monoclonal Antibodies Revenue, 2023-2028
        6.2.3 By Region - Global CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America CD38 Monoclonal Antibodies Revenue, 2017-2028
        6.3.2 US CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.3.3 Canada CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.3.4 Mexico CD38 Monoclonal Antibodies Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe CD38 Monoclonal Antibodies Revenue, 2017-2028
        6.4.2 Germany CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.4.3 France CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.4.4 U.K. CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.4.5 Italy CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.4.6 Russia CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.4.7 Nordic Countries CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.4.8 Benelux CD38 Monoclonal Antibodies Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia CD38 Monoclonal Antibodies Revenue, 2017-2028
        6.5.2 China CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.5.3 Japan CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.5.4 South Korea CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.5.5 Southeast Asia CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.5.6 India CD38 Monoclonal Antibodies Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America CD38 Monoclonal Antibodies Revenue, 2017-2028
        6.6.2 Brazil CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.6.3 Argentina CD38 Monoclonal Antibodies Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CD38 Monoclonal Antibodies Revenue, 2017-2028
        6.7.2 Turkey CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.7.3 Israel CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.7.4 Saudi Arabia CD38 Monoclonal Antibodies Market Size, 2017-2028
        6.7.5 UAE CD38 Monoclonal Antibodies Market Size, 2017-2028
7 Players Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Corporate Summary
        7.1.2 Johnson & Johnson Business Overview
        7.1.3 Johnson & Johnson CD38 Monoclonal Antibodies Major Product Offerings
        7.1.4 Johnson & Johnson CD38 Monoclonal Antibodies Revenue in Global Market (2017-2022)
        7.1.5 Johnson & Johnson Key News
    7.2 Sanofi
        7.2.1 Sanofi Corporate Summary
        7.2.2 Sanofi Business Overview
        7.2.3 Sanofi CD38 Monoclonal Antibodies Major Product Offerings
        7.2.4 Sanofi CD38 Monoclonal Antibodies Revenue in Global Market (2017-2022)
        7.2.5 Sanofi Key News
    7.3 Janssen Biotech
        7.3.1 Janssen Biotech Corporate Summary
        7.3.2 Janssen Biotech Business Overview
        7.3.3 Janssen Biotech CD38 Monoclonal Antibodies Major Product Offerings
        7.3.4 Janssen Biotech CD38 Monoclonal Antibodies Revenue in Global Market (2017-2022)
        7.3.5 Janssen Biotech Key News
    7.4 Carbosynth
        7.4.1 Carbosynth Corporate Summary
        7.4.2 Carbosynth Business Overview
        7.4.3 Carbosynth CD38 Monoclonal Antibodies Major Product Offerings
        7.4.4 Carbosynth CD38 Monoclonal Antibodies Revenue in Global Market (2017-2022)
        7.4.5 Carbosynth Key News
    7.5 Creative Biolabs
        7.5.1 Creative Biolabs Corporate Summary
        7.5.2 Creative Biolabs Business Overview
        7.5.3 Creative Biolabs CD38 Monoclonal Antibodies Major Product Offerings
        7.5.4 Creative Biolabs CD38 Monoclonal Antibodies Revenue in Global Market (2017-2022)
        7.5.5 Creative Biolabs Key News
    7.6 BOC Sciences
        7.6.1 BOC Sciences Corporate Summary
        7.6.2 BOC Sciences Business Overview
        7.6.3 BOC Sciences CD38 Monoclonal Antibodies Major Product Offerings
        7.6.4 BOC Sciences CD38 Monoclonal Antibodies Revenue in Global Market (2017-2022)
        7.6.5 BOC Sciences Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. CD38 Monoclonal Antibodies Market Opportunities & Trends in Global Market
    Table 2. CD38 Monoclonal Antibodies Market Drivers in Global Market
    Table 3. CD38 Monoclonal Antibodies Market Restraints in Global Market
    Table 4. Key Players of CD38 Monoclonal Antibodies in Global Market
    Table 5. Top CD38 Monoclonal Antibodies Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global CD38 Monoclonal Antibodies Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global CD38 Monoclonal Antibodies Revenue Share by Companies, 2017-2022
    Table 8. Global Companies CD38 Monoclonal Antibodies Product Type
    Table 9. List of Global Tier 1 CD38 Monoclonal Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 CD38 Monoclonal Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - CD38 Monoclonal Antibodies Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - CD38 Monoclonal Antibodies Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - CD38 Monoclonal Antibodies Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - CD38 Monoclonal Antibodies Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global CD38 Monoclonal Antibodies Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global CD38 Monoclonal Antibodies Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2023-2028
    Table 30. Johnson & Johnson Corporate Summary
    Table 31. Johnson & Johnson CD38 Monoclonal Antibodies Product Offerings
    Table 32. Johnson & Johnson CD38 Monoclonal Antibodies Revenue (US$, Mn), (2017-2022)
    Table 33. Sanofi Corporate Summary
    Table 34. Sanofi CD38 Monoclonal Antibodies Product Offerings
    Table 35. Sanofi CD38 Monoclonal Antibodies Revenue (US$, Mn), (2017-2022)
    Table 36. Janssen Biotech Corporate Summary
    Table 37. Janssen Biotech CD38 Monoclonal Antibodies Product Offerings
    Table 38. Janssen Biotech CD38 Monoclonal Antibodies Revenue (US$, Mn), (2017-2022)
    Table 39. Carbosynth Corporate Summary
    Table 40. Carbosynth CD38 Monoclonal Antibodies Product Offerings
    Table 41. Carbosynth CD38 Monoclonal Antibodies Revenue (US$, Mn), (2017-2022)
    Table 42. Creative Biolabs Corporate Summary
    Table 43. Creative Biolabs CD38 Monoclonal Antibodies Product Offerings
    Table 44. Creative Biolabs CD38 Monoclonal Antibodies Revenue (US$, Mn), (2017-2022)
    Table 45. BOC Sciences Corporate Summary
    Table 46. BOC Sciences CD38 Monoclonal Antibodies Product Offerings
    Table 47. BOC Sciences CD38 Monoclonal Antibodies Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. CD38 Monoclonal Antibodies Segment by Type in 2021
    Figure 2. CD38 Monoclonal Antibodies Segment by Application in 2021
    Figure 3. Global CD38 Monoclonal Antibodies Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global CD38 Monoclonal Antibodies Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global CD38 Monoclonal Antibodies Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by CD38 Monoclonal Antibodies Revenue in 2021
    Figure 8. By Type - Global CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
    Figure 9. By Application - Global CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
    Figure 10. By Region - Global CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
    Figure 11. By Country - North America CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
    Figure 12. US CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
    Figure 16. Germany CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 17. France CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
    Figure 24. China CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 28. India CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
    Figure 30. Brazil CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa CD38 Monoclonal Antibodies Revenue Market Share, 2017-2028
    Figure 33. Turkey CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE CD38 Monoclonal Antibodies Revenue, (US$, Mn), 2017-2028
    Figure 37. Johnson & Johnson CD38 Monoclonal Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Sanofi CD38 Monoclonal Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Janssen Biotech CD38 Monoclonal Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Carbosynth CD38 Monoclonal Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Creative Biolabs CD38 Monoclonal Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. BOC Sciences CD38 Monoclonal Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
CD38 Monoclonal Antibodies Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CD38 Monoclonal Antibodies Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CD38 Monoclonal Antibodies Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports